Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...

Buying $100 In GMED: If an investor had bought $100 of GMED stock 10 years ago, it would be worth $356.36 today based on a price of $86.88 for GMED at the time of writing.

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Can Cui joined Greenberg Traurig as a shareholder in its life sciences and medical technology practice in Austin, the firm ...

RadiusXR, a leader in transforming vision testing and eye care with advanced digital health platforms, is thrilled to ...

Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...